COMMUNIQUÉS West-GlobeNewswire

WORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective March 6, 2025

05/03/2025 - 22:01

Hangzhou, China, March 05, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices, through its subsidiary, Work (Hangzhou) Medical [...]

Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

05/03/2025 - 22:01

Phase 1 Dose Expansion Initiated for FT819 Off-the-Shelf CAR T-cell Product Candidate with Fludarabine-free Conditioning in Moderate-to-Severe SLE Completed Type D Meeting with FDA to Enable FT819 Off-the-Shelf CAR T- [...]

Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

05/03/2025 - 22:01

Initiated Anaphylm™ (epinephrine) Sublingual Film NDA filing process with FDA Anaphylm pre-commercial activities underway; launch expected in Q1 2026, if approved by the FDA Initial Anaphylm pediatric clinical trial [...]

Plus Therapeutics Announces New Employment Inducement Grants

05/03/2025 - 22:01

HOUSTON, March 05, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform [...]

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05/03/2025 - 22:00

WESTLAKE VILLAGE, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology [...]

Natural Alternatives International and CarnoSyn® Brands Publish Clinical Research Demonstrating TriBsyn™ Delivering Exceptional Bioavailability, Increased Efficiency and Paresthesia Elimination

05/03/2025 - 21:20

CARLSBAD, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) and CarnoSyn® Brands today announced the publication of positive clinical trial results in the journal Food [...]

Andromeda Surgical Announces Strategic Partnerships with Richard Wolf and Quanta System, Accelerating Global Growth and Clinical Development

05/03/2025 - 20:07

First Surgical Robot Designed for Continuous Software Evolution—Initial Focus on HoLEP, with Expansion into Other Disease States SOUTH SAN FRANCISCO, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Andromeda Surgical , a [...]

iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America

05/03/2025 - 20:04

NASHUA, N.H. and TORONTO, March 05, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc . (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and RamSoft ® , a global leader in cloud-based RIS/PACS [...]

Holland Bloorview leads national precision health initiative for children and youth

05/03/2025 - 19:42

$12 million investment will sequence genes of 10,000 individuals targeted at neurodevelopmental conditions, mental health and brain injuries TORONTO, March 05, 2025 (GLOBE NEWSWIRE) -- Holland Bloorview Kids [...]

AAPA, PA Foundation leading efforts to improve colorectal cancer screening rates

05/03/2025 - 19:15

ALEXANDRIA, Va., March 05, 2025 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA) is proud to lead an effort aimed at improving screening rates for colorectal cancer, which is the third deadliest [...]

NTG Nordic Transport Group Annual Report for 2024

05/03/2025 - 19:05

Company announcement no. 2 – 25 05 March 2025 NTG Nordic Transport Group Annual Report for 2024 NTG Nordic Transport Group A/S (“NTG”) has today published the 2024 Annual Report. Selected financial highlights are [...]

Siren Biotechnology Expands Clinical and Scientific Advisory Board with Key Industry Leaders

05/03/2025 - 18:15

SAN FRANCISCO, March 05, 2025 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for Cancer, today announced the appointment of three distinguished industry and academic experts to [...]

Press release: Sanofi successfully prices EUR 1.5 billion of bond issue

05/03/2025 - 18:10

Sanofi successfully prices EUR 1.5 billion of bond issue Paris, March 5, 2025. Sanofi announces that it has successfully priced its offering of EUR 1.5 billion of notes across 2 tranches: €850 million floating rate [...]

Communiqué de presse : Sanofi place 1,5 milliard d’euros d’emprunts obligataires

05/03/2025 - 18:10

Sanofi place 1,5 milliard d’euros d’emprunts obligataires Paris, 5 mars 2024. Sanofi annonce avoir placé avec succès une émission obligataire en 2 tranches (les « obligations ») pour un montant de 1,5 milliard d’euros [...]

VALNEVA Declaration of shares and voting rights: February 28, 2025

05/03/2025 - 18:00

VALNEVA Declaration of shares and voting rights February 28, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, [...]

VALNEVA Déclaration d’actions et de droits de vote : 28 février 2025

05/03/2025 - 18:00

VALNEVA Déclaration d’actions et de droits de vote 28 février 2025 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 [...]

BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper

05/03/2025 - 17:00

KUALA LUMPUR, Malaysia, March 06, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in technology and healthcare, is pleased to announce that its Board of [...]

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

05/03/2025 - 16:00

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 5 March 2025 at 17.00 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]

Longeveron® to Present at the 37th Annual Roth Conference

05/03/2025 - 15:25

MIAMI, March 05, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]